Genomictree
Latest round
- Series C
Last raised
- Sep 2017
Total raised
- $8.5M
Investors
- 2
About Genomictree
Based in Daejeon, South Korea and established in 2010, Genomictree, Inc. is a molecular diagnostic company which develops molecular diagnostic technology and product for the diagnostics of cancer and various infectious diseases. It provides DNA methylation biomarker-based non-invasive cancer molecular diagnostic product for cancer detection.
Who invested in Genomictree
2 investors across 2 rounds
See all investors in Genomictree
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Genomictree
Who invested in Genomictree?
Genomictree has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genomictree raised?
Genomictree has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Genomictree last raise money?
Genomictree's most recent round on record is a Series C, in Sep 2017.
What does Genomictree do?
Based in Daejeon, South Korea and established in 2010, Genomictree, Inc.
Where is Genomictree headquartered?
Genomictree is headquartered in Daejeon, South Korea.
Which VCs invest in companies like Genomictree?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Genomictree's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Genomictree? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.